tiprankstipranks
Trending News
More News >
Revolution Medicines (RVMD)
NASDAQ:RVMD
US Market

Revolution Medicines (RVMD) Income Statement

Compare
377 Followers

Revolution Medicines Income Statement

Last quarter (Q4 2024), Revolution Medicines's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Revolution Medicines's net income was $-194.57M. See Revolution Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 11.58M$ 35.38M$ 29.39M$ 42.98M
Gross Profit
$ 0.00$ 11.58M$ 25.72M$ 22.06M$ -89.27M
Operating Expenses
$ 689.52M$ 498.76M$ 293.66M$ 217.40M$ 153.68M
Depreciation and Amortization
$ 0.00$ 9.31M$ 9.66M$ 7.33M$ 6.54M
EBITDA
$ -689.52M$ -430.58M$ -239.47M$ -179.75M$ -101.91M
Operating Income
$ -689.52M$ -487.19M$ -258.28M$ -188.01M$ -110.70M
Other Income/Expenses
$ 88.68M$ 47.29M$ 9.15M$ 917.00K$ 2.17M
Pretax Income
$ -600.85M$ -439.89M$ -249.13M$ -187.09M$ -108.53M
Net Income
$ -600.09M$ -436.37M$ -248.71M$ -179.77M$ -108.16M
Per Share Metrics
Basic EPS
$ -3.58$ -3.86$ -3.08$ -2.47$ -1.62
Diluted EPS
$ -3.58$ -3.86$ -3.08$ -2.47$ -1.62
Weighted Average Shares Outstanding
167.74M 113.15M 80.63M 72.81M 66.60M
Weighted Average Shares Outstanding (Diluted)
167.74M 113.15M 80.63M 72.81M 66.60M
Currency in USD

Revolution Medicines Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis